Company: APXIF
Filing Date: 2025-07-03
Form Type: F-4/A
Source: 0001213900-25-061545
Chunk: 21

Company: APx Acquisition Corp. I
Filing Date: 2025-07-03
Form: F-4/A
Chunk 21
---
17, 2024 and (iii) a Form 25 -NSEwill be filed with the SEC, which will remove APx’s securities from listing and registration on Nasdaq. Under Rule IM -5101-2, a special purpose acquisition company must complete one or more business combinations within 36months of the effectiveness of its initial public offering registration statement. Since APx failed to complete our initial business combination by December6, 2024, Nasdaq’s staff concluded that APx did not comply with Rule IM -5101-2and that APx’s securities are now subject to delisting. As a result, trading in APx’s securities on Nasdaq was effectively suspended with the open of the market on December17, 2024, and APx’s securities are currently eligible to trade only on the over -the-countermarkets system.

On March21, 2025, Nasdaq filed a Form 25 -NSEin respect of APx’s Class A ordinary shares with the SEC, and the delisting of APx’s Class A ordinary shares became effective on March31, 2025. On May8, 2025, Nasdaq filed a Form 25 -NSEin respect of APx’s units and warrants with the SEC, and the delisting of APx’s units and warrants will become effective on May18, 2025. Following the delisting on Nasdaq, APx’s Class A ordinary shares are quoted on the Pink Open Market of the OTC under the symbol “APXIF”. We will remain a reporting entity under the Securities Exchange Act of 1934, as amended, with respect to continued disclosure of financial and operational information. For more information on the consequences of the delisting of our securities, or the failure to establish and maintain a listing for the Company Shares and Company Warrants, see “ Risk Factors — Additional Risks Related to the Business Combination — A market for our securities may not continue, which would adversely affect the liquidity and price of our securities,” “Risk Factors — Risks Related to APx — Our securities have been delisted from Nasdaq. The delisting of our securities may delay, or ultimately prevent, the consummation of the Business Combination,” and “Risk Factors — Risks Related to APx — Following the delisting of our securities from Nasdaq, we could become subject to the “penny stock” rules, the ability of our investors to sell our securities will likely be adversely impacted, and we may be unable to consummate the